Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials. (linkinghub.elsevier.com)

Authors: Guttman-Yassky E … Bissonnette R Journal: The Lancet Published: 2026-01-03 DOI: https://doi.org/10.1016/S0140-6736(25)01865-3